Alzheimer's
Sam Altman-backed AI biotech announces $1 billion for its lofty goal: adding 10 years to human lifespan
Micheal
Retro Biosciences will back clinical trials for three drugs—including a potential Alzheimer’s disease treatment set to begin studies this year. ...
Drugs like Ozempic may reduce risks in dozens of health outcomes
Micheal
© 2024 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use ...
